Neuroprotection by agmatine: Possible involvement of the gut microbiome?

Priyanka Saha,Subhrajita Panda,Aayusha Holkar,Rahul Vashishth,Sandeep Singh Rana,Mohanapriya Arumugam,Ghulam Md Ashraf,Shafiul Haque,Faraz Ahmad
DOI: https://doi.org/10.1016/j.arr.2023.102056
IF: 11.788
2023-11-01
Ageing Research Reviews
Abstract:Agmatine, an endogenous polyamine derived from L-arginine, elicits tremendous multimodal neuromodulant properties. Alterations in agmatinergic signalling are closely linked to the pathogeneses of several brain disorders. Importantly, exogenous agmatine has been shown to act as a potent neuroprotectant in varied pathologies, including brain ageing and associated comorbidities. The antioxidant, anxiolytic, analgesic, antidepressant and memory-enhancing activities of agmatine may derive from its ability to regulate several cellular pathways; including cell metabolism, survival and differentiation, nitric oxide signalling, protein translation, oxidative homeostasis and neurotransmitter signalling. This review briefly discusses mammalian metabolism of agmatine and then proceeds to summarize our current understanding of neuromodulation and neuroprotection mediated by agmatine. Further, the emerging exciting bidirectional links between agmatine and the resident gut microbiome and their implications for brain pathophysiology and ageing are also discussed.
cell biology,geriatrics & gerontology,gerontology
What problem does this paper attempt to address?